Furthermore, the Nrf2 pathway acts as a driver of cancer progression and is resistant to radiotherapy as well as chemotherapy, but still the oncogenic role of Nrf2 is controversial due to its contribution in overcoming chemical carcinogenesis. Here, NFE2L2 is linked to cancer.